Cross Country Healthcare, Inc. (CCRN) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
CCRN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
CCRN Revenue Analysis (2013–2024)
As of March 1, 2026, Cross Country Healthcare, Inc. (CCRN) generated trailing twelve-month (TTM) revenue of $1.13 billion, reflecting significant decline in growth of -20.6% year-over-year. The most recent quarter (Q3 2025) recorded $250.1 million in revenue, down 8.8% sequentially.
Looking at the longer-term picture, CCRN's 5-year compound annual growth rate (CAGR) stands at +10.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $2.80 billion in 2022.
Revenue diversification analysis shows CCRN's business is primarily driven by Other Services (100%). With over half of revenue concentrated in Other Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including SOLV (+0.9% YoY), HCSG (+6.3% YoY), and AMN (-8.5% YoY), CCRN has underperformed the peer group in terms of revenue growth. Compare CCRN vs SOLV →
Peer Comparison
Compare CCRN's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CCRNCurrent | $1.1B | -20.6% | +10.3% | -1.3% | |
| SOLV | $8.3B | +0.9% | - | 26.2% | |
| HCSG | $1.8B | +6.3% | +0.9% | 2.6% | |
| AMN | $3.0B | -8.5% | +6.1% | -3.4% | |
| CCEL | $32M | -0.3% | +0.1% | 10.9% | |
| AMS | $28M | +17.8% | +6.6% | -9.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1.34B | -33.5% | $274.3M | 20.4% | $-16,865,000 | -1.3% |
| 2023 | $2.02B | -28.0% | $450.4M | 22.3% | $112.7M | 5.6% |
| 2022 | $2.80B | +67.2% | $624.5M | 22.3% | $269.9M | 9.6% |
| 2021 | $1.68B | +100.5% | $375.0M | 22.4% | $139.3M | 8.3% |
| 2020 | $836.4M | +1.7% | $202.7M | 24.2% | $-9,160,000 | -1.1% |
| 2019 | $822.2M | +0.7% | $204.0M | 24.8% | $-15,711,000 | -1.9% |
| 2018 | $816.5M | -5.6% | $209.6M | 25.7% | $-12,880,000 | -1.6% |
| 2017 | $865.0M | +3.8% | $228.6M | 26.4% | $11.7M | 1.4% |
| 2016 | $833.5M | +8.6% | $221.7M | 26.6% | $6.2M | 0.7% |
| 2015 | $767.4M | +24.2% | $197.4M | 25.7% | $20.6M | 2.7% |
See CCRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCRN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CCRN vs AGIO
See how CCRN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CCRN's revenue growth accelerating or slowing?
CCRN revenue declined -20.6% year-over-year, contrasting with the 5-year CAGR of +10.3%. TTM revenue fell to $1.1B. This reverses the prior growth trend.
What is CCRN's long-term revenue growth rate?
Cross Country Healthcare, Inc.'s 5-year revenue CAGR of +10.3% reflects the variable expansion pattern. Current YoY growth of -20.6% is below this long-term average.
How is CCRN's revenue distributed by segment?
CCRN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.